Overview
Lobbying Costs
50,000€ - 99,999€
Financial year: Jan 2023 - Dec 2023
Lobbyists (Full time equivalent)
0.75 Fte (2)
Lobbyists with EP accreditation
0
High-level Commission meetings
1
Lobbying Costs over the years
-
Info
Zentiva Group a.s. (Zentiva)
EU Transparency Register
888725551808-41 First registered on 02 Nov 2023
Goals / Remit
Zentiva is a pharmaceutical company committed to ensuring the availability of high-quality and affordable medicines for patients around the EU. With a robust infrastructure including four manufacturing sites located in Prague, Bucharest, and Ankleshwar, we ensure a steady flow of essential medicines to the market. Our operations covers over 30 countries with almost 5000 employees dedicated to serving patients, HCO/HCP and other professionals, thereby facilitating the broad accessibility of our medicines. As a leading manufacturer of generics, our business model emphasizes the accessibility and affordability of our products, while our two R&D centre in Prague reflect our investment in research aimed at enhancing the quality of life for patients and consumers.
Main EU files targeted
Healthcare generally, Public Health, Industiral Affairs, Medicines Production, Pharmaceutical legisltion, Pricing and Reimbursement Policies.
Mainly Pharmaceutical Legislation:
- Regulation 726/2004
- Directive 2001/83/EC
- Regulation 1901/2006
- Regulation 141/2000/EC
Industrial:
- The Urban Waste Water Treatment Directive (UWWTD) - Council Directive 91/271/EECAddress
Head Office
U kabelovny 16
Praha 10 10200
CZECH REPUBLICEU Office
U kabelovny 16
Praha 10 10200
CZECH REPUBLICWebsite
-
People
Total lobbyists declared
2
Employment time Lobbyists 50% 1 25% 1 Lobbyists (Full time equivalent)
0.75
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
1 person half-time, 1 person only partialy focusing on EU topics (less than 25%)
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Companies & groups
-
Networking
Affiliation
Medicines for Europe - https://www.medicinesforeurope.com/
Member organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2023 - Dec 2023
Lobbying costs for closed financial year
50,000€ - 99,999€
Major contributions in closed year
Type Name Amount Grant Národní plán obnovy ČR 267,543€ Intermediaries for closed year
None declaredIntermediaries for current year
None declaredClosed year Costs
50,000€ - 99,999€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
None declared
Groups (European Parliament)
N/A
Communication activities
- Access to Healthcare
- Industrial policy
- Medicines Manufacturing policy
- Trade agreements
- Intelectual Property
- CSR
- Sustainability
- Regulatory Affairs - MedicinesOther activities
None declared
Meetings
Meetings
1 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 23 Nov 2023 Location Brussels Subject Competitiveness, green and digital transition Cabinet Cabinet of Vice-President Věra Jourová Portfolio Values and Transparency Attending - Věra Jourová (Vice-President)
Other Lobbyists